AEON Biopharma, Inc. (AEON)
AEON Biopharma, Inc. (AEON) has a 10-report earnings history dating back to Nov 13, 2023. Its average absolute post-earnings move is ±6.62%, and 30.0% of those reactions were positive. Its largest post-earnings gain was +21.16% (Aug 12, 2025) and its largest decline was -12.79% (Nov 13, 2024). The next earnings report is predicted for 2026-08-12 (estimated).
Earnings reactions
How AEON moved on each past earnings report.
Earnings Impact
Total Earnings
10
Avg Abs. Movement
±6.62%
Positive %
30.0%
Negative %
70.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 14, 2026 | ☽ POST | -11.04% | open_in_new |
| Mar 30, 2026 | ☽ POST | +0% | open_in_new |
| Nov 14, 2025 | ☀ PRE | +0% | open_in_new |
| Aug 12, 2025 | ☽ POST | +21.16% | open_in_new |
Earnings Count
10
Total earnings in dataset
Avg Abs. Movement
±6.62%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260723 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260721 | open_in_new SEC.gov |
| 424B4 | 20260715 | open_in_new SEC.gov |
| 8-K | 20260715 | open_in_new SEC.gov |
| S-1MEF | 20260713 | open_in_new SEC.gov |
| EFFECT | 20260713 | open_in_new SEC.gov |
| S-1/A | 20260709 | open_in_new SEC.gov |
| S-1 | 20260708 | open_in_new SEC.gov |
| 4 | 20260622 | open_in_new SEC.gov |
| 4 | 20260622 | open_in_new SEC.gov |
Frequently asked about AEON earnings
When does AEON Biopharma, Inc. report earnings next? expand_more
AEON Biopharma, Inc. (AEON)'s next earnings date is estimated for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does AEON stock move after earnings? expand_more
Over 10 reports, AEON has moved an average of ±6.62% the session after earnings, closing higher 30.0% of the time.
What was AEON's biggest post-earnings move? expand_more
AEON's largest post-earnings gain on record was +21.16% on Aug 12, 2025, and its largest decline was -12.79% on Nov 13, 2024.
Where can I find AEON Biopharma, Inc.'s SEC filings? expand_more
All of AEON Biopharma, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right